1. Home
  2. BSVN vs ENTA Comparison

BSVN vs ENTA Comparison

Compare BSVN & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank7 Corp.

BSVN

Bank7 Corp.

HOLD

Current Price

$45.55

Market Cap

416.1M

Sector

Finance

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$12.62

Market Cap

382.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSVN
ENTA
Founded
2004
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
416.1M
382.7M
IPO Year
2018
2012

Fundamental Metrics

Financial Performance
Metric
BSVN
ENTA
Price
$45.55
$12.62
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$53.67
$20.40
AVG Volume (30 Days)
7.4K
175.3K
Earning Date
04-14-2026
05-11-2026
Dividend Yield
2.48%
N/A
EPS Growth
N/A
29.93
EPS
1.25
N/A
Revenue
N/A
$102,814,000.00
Revenue This Year
$5.05
$7.76
Revenue Next Year
$4.05
N/A
P/E Ratio
$36.78
N/A
Revenue Growth
N/A
16.48
52 Week Low
$37.61
$6.44
52 Week High
$50.10
$17.15

Technical Indicators

Market Signals
Indicator
BSVN
ENTA
Relative Strength Index (RSI) 63.62 48.63
Support Level $45.50 $11.92
Resistance Level $47.99 $13.97
Average True Range (ATR) 0.74 0.77
MACD 0.14 0.06
Stochastic Oscillator 90.81 62.86

Price Performance

Historical Comparison
BSVN
ENTA

About BSVN Bank7 Corp.

Bank7 Corp is a full-service commercial bank focused on providing customers with exceptional service and meeting their banking needs through a variety of commercial and retail financial services. It offers deposit banking products, including commercial deposit services, commercial checking, money market, and other deposit accounts, and retail deposit services such as certificates of deposit, money market accounts, checking accounts, negotiable order of withdrawal accounts, savings accounts, and automated teller machine access. etc. It generates revenues from interest income from financial instruments and non-interest income and service charges on deposit accounts.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: